Artificial Intelligence in Non-Insulin-Treated Type 2 Diabetes: From Reactive Management to Anticipatory Care
Type 2 diabetes mellitus is a highly prevalent, heterogeneous, and progressive chronic disease. In a large proportion of patients, management is based for many years on lifestyle intervention and non-insulin glucose-lowering therapies. This long pre-insulin phase represents a crucial clinical window, in which timely re...